Physical Activity Choices Everyday (PACE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03824769 |
|
Recruitment Status :
Completed
First Posted : January 31, 2019
Last Update Posted : September 30, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Obesity | Behavioral: Weight Loss Maintenance + Healthy Thinking Behavioral: Weight Loss Maintenance Treatment + Future Thinking | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 160 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Is Long-term Maintenance Worth the Wait? Using Real Time Data Capture to Examine Delayed Discounting as a Putative Target of Physical Activity Adherence in Weight Loss Maintenance Interventions |
| Actual Study Start Date : | March 11, 2019 |
| Actual Primary Completion Date : | May 3, 2021 |
| Actual Study Completion Date : | May 3, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Behavioral Weight Loss Maintenance + Healthy Thinking
Contingent upon participants losing 5% of body weight or more in Phase I (weight loss) of this trial, participants will receive a 4-month behavioral weight maintenance intervention consisting of 7 sessions that focus on evidence-based weight management strategies focused on diet, exercise, and behavioral skills. In this treatment, participants will be asked to read short passages related to nutrition and a healthy lifestyle through our study website twice a day for the duration of treatment.
|
Behavioral: Weight Loss Maintenance + Healthy Thinking
Contingent upon participants losing 5% of body weight or more in Phase I (weight loss) of this trial, participants will receive a 4-month behavioral weight maintenance intervention consisting of 7 sessions that focus on evidence-based weight management strategies focused on diet, exercise, and behavioral skills. In this treatment, participants will be asked to read short passages related to nutrition and a healthy lifestyle through our study website twice a day for the duration of treatment. |
|
Experimental: Behavioral Weight Loss Maintenance Treatment + Future Thinking
Contingent upon participants losing 5% of body weight or more in Phase I (weight loss) of this trial, participants will receive a 4-month behavioral weight maintenance intervention consisting of 7 sessions that focus on evidence-based weight management strategies focused on diet, exercise, and behavioral skills. In this treatment, participants will create descriptions of upcoming positive events and will be asked to read short passages through our study website at least twice a day for the duration of treatment.
|
Behavioral: Weight Loss Maintenance Treatment + Future Thinking
Contingent upon participants losing 5% of body weight or more in Phase I (weight loss) of this trial, participants will receive a 4-month behavioral weight maintenance intervention consisting of 7 sessions that focus on evidence-based weight management strategies focused on diet, exercise, and behavioral skills. In this treatment, participants will create descriptions of upcoming positive events and will be asked to read short passages through our study website at least twice a day for the duration of treatment. |
- Physical Activity [ Time Frame: Phase II baseline to 1 month, 2 months and 4 months (end of treatment) ]Change in minutes of moderate to vigorous physical activity measured via a waist worn accelerometer during the Phase II maintenance program.
- Delay Discounting [ Time Frame: Phase II baseline to 1 month, 2 months and 4 months (end of treatment) ]Change in delay discounting measured using a choice task during the Phase II maintenance program
- Weight [ Time Frame: 4 months ]Weight change from end of Phase 1 weight loss program to end of Phase II maintenance program
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age between 18-70
- Body Mass Index between 30-50
- English Speaking
- Have a smartphone that can be used for study activities
Exclusion Criteria:
- Report being unable to walk 2 blocks without stopping
- Are currently participating in weight loss treatment, have a history of bariatric surgery, or lost ≥5% in the past 6-months
- Are pregnant or plan to become pregnant within 1 year
- Report a heart condition, chest pain during periods of rest or activity, or loss of consciousness on the Physical Activity Readiness Questionnaire
- Report a medical condition that could jeopardize their safety in a weight control program with diet and exercise guidelines
- History of or current traumatic brain injury, dementia or Alzheimer's disease; a history of Multiple Sclerosis, or other neurological disorders
- Report conditions that, in the judgment of the PI, would render them unlikely to follow the protocol (e.g., relocation, dementia, unable to read and write in English)
- Have no Internet access or unwilling to use personal smartphone for study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03824769
| United States, Connecticut | |
| UConn Weight Management Research Laboratory | |
| Hartford, Connecticut, United States, 06103 | |
| Principal Investigator: | Amy Gorin, PhD | University of Connecticut |
| Responsible Party: | Amy Gorin, Director, Institute for Collaboration on Health, Intervention, and Policy Professor, Psychological Sciences, University of Connecticut |
| ClinicalTrials.gov Identifier: | NCT03824769 |
| Other Study ID Numbers: |
H18-153 R21NR018359 ( U.S. NIH Grant/Contract ) |
| First Posted: | January 31, 2019 Key Record Dates |
| Last Update Posted: | September 30, 2021 |
| Last Verified: | September 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Weight Loss Maintenance |

